When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Diffuse large B-cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/Diffuse_large_B-cell_lymphoma

   Diffuse large B-cell lymphoma (DLBCL) is a cancer of B cells, a type of lymphocyte that is responsible for producing antibodies.It is the most common form of non-Hodgkin lymphoma among adults, [1] with an annual incidence of 7–8 cases per 100,000 people per year in the US and UK.

3. B-cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/B-cell_lymphoma

   The B-cell lymphomas are types of lymphoma affecting B cells. Lymphomas are "blood cancers" in the lymph nodes . They develop more frequently in older adults and in immunocompromised individuals.

4. Germinal center B-cell like diffuse large B-cell lymphoma

   en.wikipedia.org/wiki/Germinal_center_B-cell...

   Cell death does not appear to be mediated by complement, but modest antibody-dependent cellular cytotoxicity and direct killing effects have been demonstrated. [12] CD70. In normal lymphoid tissues CD27 and its ligand CD70 have a restricted expression pattern, but a 1999 study found CD70 on 71% of large B-cell lymphomas. [13]

5. Primary central nervous system lymphoma - Wikipedia

   en.wikipedia.org/wiki/Primary_central_nervous...

   Primary central nervous system lymphoma (PCNSL), also termed primary diffuse large B-cell lymphoma of the central nervous system (DLBCL-CNS), [2] is a primary intracranial tumor appearing mostly in patients with severe immunodeficiency (typically patients with AIDS). It is a subtype and one of the most aggressive of the diffuse large B-cell ...

6. T cell/histiocyte-rich large B-cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/T_cell/histiocyte-rich...

   Among the various forms of B-cell lymphomas, THRLBCL is a rarely occurring subtype of the diffuse large B-cell lymphomas (DLBCL). DLBCL are a large group of lymphomas that account for ~25% of all non-Hodgkin lymphomas worldwide. [1] THRLBCL is distinguished from the other DLBCL subtypes by the predominance of non-malignant T-cell lymphocytes ...

7. The year in cancer: Advances made in 2024, predictions for 2025

   www.aol.com/cancer-advances-made-2024...

   The five-year survival for patients with a diagnosis of stage 4 melanoma was less than 5% before 2010, and now clinical trials have shown that more than 50% of patients are still alive 10 years ...